Capital World Investors Seer, Inc. Transaction History

Capital World Investors

$597 Billion
Q2 2024

A detailed history of Capital World Investors transactions in Seer, Inc. stock. As of the latest transaction made, Capital World Investors holds 2,056,000 shares of SEER stock, worth $3.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,056,000

Previous 2,056,000 -0.0%

Holding current value

$3.68 Million

Previous $3.91 Million 11.57%

% of portfolio

0.0%

Previous 0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$1.47 - $2.22 $3.01 Million - $4.54 Million	-2,046,472 Reduced 49.88%	2,056,000 $3.99 Million
Q3 2023 Nov 13, 2023	SELL	$2.18 - $5.52 $1.24 Million - $3.14 Million	-568,528 Reduced 12.17%	4,102,472 $9.07 Million
Q4 2022 Feb 14, 2023	BUY	$5.03 - $8.58 $1.29 Million - $2.2 Million	256,332 Added 5.81%	4,671,000 $27.1 Million
Q3 2022 Nov 14, 2022	BUY	$7.7 - $13.31 $12.3 Million - $21.3 Million	1,597,002 Added 56.68%	4,414,668 $34.2 Million
Q2 2022 Aug 15, 2022	BUY	$6.72 - $16.07 $4.35 Million - $10.4 Million	647,666 Added 29.85%	2,817,666 $25.2 Million
Q1 2022 May 16, 2022	BUY	$11.88 - $23.4 $9.5 Million - $18.7 Million	800,000 Added 58.39%	2,170,000 $33.1 Million
Q2 2021 Aug 16, 2021	BUY	$28.75 - $56.92 $5.32 Million - $10.5 Million	185,101 Added 15.62%	1,370,000 $44.9 Million
Q1 2021 May 14, 2021	BUY	$38.67 - $84.06 $14.1 Million - $30.7 Million	364,899 Added 44.5%	1,184,899 $59.3 Million
Q4 2020 Feb 12, 2021	BUY	$55.23 - $81.11 $45.3 Million - $66.5 Million	820,000 New	820,000 $46 Million

Others Institutions Holding SEER

# of Institutions

Shares Held

39.7M

Call Options Held

100

Put Options Held

100

View Full List

About Seer, Inc.

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $105M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

More about SEER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account

Capital World Investors Seer, Inc. Transaction History